$10.32
-0.43-4.00%
At Close: -
$10.51
0.191.84%
After Hours: 5:06 PM EDT
15 minutes delayed
Comments
Loading...
ARS Pharmaceuticals
SPRYNASDAQ
ARS Pharmaceuticals (NASDAQ:SPRY) Stock, Earnings Estimates, EPS, And Revenue
ARS Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-0.120
Quarterly Revenue Estimate
$1M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$10K
Analyze the earnings history of ARS Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals | -$0.18 | -$0.12 | — | — | $10.00K | $1.00M | — | — | 08/08/2024 | Get Alert |
| SPRY | ARS Pharmaceuticals | -$0.16 | -$0.11 | -$0.11 | 0.00% | $20.00K | — | $0.00 | — | 05/09/2024 | Get Alert |
| SPRY | ARS Pharmaceuticals | — | -$0.14 | -$0.07 | 50.00% | — | — | $0.00 | — | 03/21/2024 | Get Alert |
| SPRY | ARS Pharmaceuticals | -$0.21 | — | -$0.16 | — | — | — | $0.00 | — | 11/09/2023 | Get Alert |
| SPRY | ARS Pharmaceuticals | -$0.21 | -$0.17 | -$0.18 | -5.88% | $464.00K | — | $10.00K | — | 08/10/2023 | Get Alert |
| SPRY | ARS Pharmaceuticals | — | -$0.17 | -$0.16 | 5.88% | — | — | $20.00K | — | 05/15/2023 | Get Alert |
ARS Pharmaceuticals (SPRY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.11 | $-0.11 | 0.00 % |
| Dec 2023 | 2024-03-21 | $-0.07 | $-0.14 | 50.0 % |
| Jun 2023 | 2023-08-10 | $-0.18 | $-0.17 | -5.88 % |
| Mar 2023 | 2023-05-15 | $-0.16 | $-0.17 | 5.88 % |
ARS Pharmaceuticals (SPRY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is ARS Pharmaceuticals (NASDAQ:SPRY) reporting earnings?
ARS Pharmaceuticals (SPRY) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for ARS Pharmaceuticals (NASDAQ:SPRY)?
The Actual EPS was $-0.11, which hit the estimate of $-0.11.
What were ARS Pharmaceuticals’s (NASDAQ:SPRY) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.